Global Longlife Hospital and Research Ltd IPO

  • Min. Investment140000/ 1000 Shares
  • Min. Quantity1000
  • Price Range₹140
  • Date Range21 Apr 22 - 25 Apr 22
  Retail Investor can invest upto Rs 2,00,000 in IPO
Dates
  • Application Start Date21 Apr 2022
  • Application End Date25 Apr 2022
  • Allotment begins
  • Refund Initiation Date
  • Allotment Date
  • Listing On Exchange
Registrar Information
  • NameBigshare Services Pvt Ltd
  • Contact no.+91 22-62638200
  • Email IDipo@bigshareonline.com
Company Information

Incorporated in 1983, Kolkata-based Tarsons Products manufactures laboratory products that are used in various research organisations, pharmaceutical companies, academia institutes, hospitals and diagnostic centres.

The company plans to go public and here’s all you need to know about this IPO.

Financial information

Here’s the consolidated financial information for the last three years:

Particulars FY19 FY20 FY21
(Rs Crore)
Revenue 34.54 33.54 32.7
Net Profit 1.36 -0.86 1.04
Total Assets 44.21 41.91 36.39
Strengths
  • Ultra-Modern Medicinal Practices
  • Prime Location of its Hospital
  • Team of Medical Practitioners
  • Clinical excellence and affordable health care
  • Grow its presence in adjacent Markets.
Risks
  • Discontinuation of association by doctors and other healthcare professionals with its hospitals for any reason, and its inability to retain them may adversely affect its business and results of operations.
  • If the company is unable to keep abreast with technological changes, new equipment and service introductions, changes in patients' needs and evolving industry standards, its business and financial condition may be adversely affected. Further, its will also incur costs associated with replacing obsolete equipment.
  • The Industry in highly regulated industry requires compliances of various laws and regulations as the human life is involved.
  • The company's business requires its to obtain a number of approvals, NOCs, licenses, registrations and permits and renew certain registrations, licenses and permits from government and regulatory authorities as well. Failure to obtain them or renewal of them in a timely manner may adversely affect its business operations.
  • The Company has given short term loans/advances to Directors, which is not in compliance with the provisions of Section 185/295 of the Companies Act, 2013/1956.
Opportunities
  • Ultra-Modern Medicinal Practices
  • Prime Location of its Hospital
  • Team of Medical Practitioners
  • Clinical excellence and affordable health care
  • Grow its presence in adjacent Markets.
What is Pre Apply?

Pre Apply will allow you to apply for an IPO 1-3 days before the bidding period starts. You'll get the UPI payment mandate once the IPO is open.

Learn more about Pre applying
How to Apply?

Select the IPO you want to apply for from the list of open issues. Enter your correct UPI ID and select the investor type. The quantity should be a multiple of the lot size. If you wish to apply at the cut-off price, simply click on the checkbox next to ’Cut-off price’. You will receive an SMS from the NPCI confirming your bid and requesting you to accept the mandate on your UPI app. We have noticed a significant delay in UPI payment SMS/notifications from NPCI. Request you to be patient. Please ignore this message if you’ve accepted the mandate

How to check your IPO allocation status

Tarsons Products allotment status will be available on or around 23 November 2021. The allotted shares will be credited to the demat account by 25 November 2021. We will provide you with the link to check the allocation’s status as soon as the registrar makes it live. This may happen after the IPO is closed (after 17 November 2021).

Andheri Office :
Unit No. 502, 5th Floor,Leela Business Park , Andheri Kurla Road,Near Airport Road Metro Station,
Andheri (E),Mumbai – 400 059. Tel No : 1800 210 0818

Registered Office:
Unit No. 506, 5th Floor, Windsor Bldg, Off CST Road, Kalina, Santacruz (E), Mumbai – 400 098.
CIN Number : U65990MH2017FTC300493


Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limits. Statutory Charges/Taxes would be levied as applicable.

Compliance Officer: Mr. Himanshu Parekh (Stock Broking and DP Activities) Email - compliance.officer@mstock.com, Tel No: - 022-41887777

Mirae Asset Capital Markets (India) Private Limited (“MACM”) offer its online retail stock broking services under brand m.Stock
Registration Details: SEBI Stock Broker Registration No.: INZ000163138 – Membership in BSE – Cash Segment (Clearing Member ID: 6681), BSE Star MF Segment (Membership No : 53975) and in NSE – Cash, F&O and CD Segments (Member ID: 90144), Membership in MCX – (Member ID: 56980), SEBI Merchant Banking Registration No.: MB/INM000012485, SEBI Research Analyst Registration No.: INH000007526, SEBI DP Registration No: IN-DP-589-2021, CDSL DP ID: 12092900, CIN: U65990MH2017FTC300493. AMFI Registered Mutual Funds Distributor: ARN-188742.Tele No: 18002100818. In case of any grievances, please write to help@mstock.com
*Special Administrative Region of the People's Republic of China
**Account would be opened after all procedure relating to IPV and client due diligence is completed.